WHO ICTRP trial
A multicenter, randomized, double-blind, parallel-group, placebo-controlled…
ChiCTR2500112323 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500112323 |
|---|---|
| Public title | A multicenter, randomized, double-blind, parallel-group, placebo-controlled phase II clinical study to explore the efficacy and safety of different doses of CMS-D002 capsule in participants with uterine fibroids associated with menorrhagia |
| Scientific title | A multicenter, randomized, double-blind, parallel-group, placebo-controlled phase II clinical study to explore the efficacy and safety of different doses of CMS-D002 capsule in participants with uterine fibroids associated with menorrhagia |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Uterine fibroids with menorrhagia |
| Interventions | Group A:CMS-D002 Capsules 10 mg, QD;Group B:CMS-D002 Capsules 25 mg, QD;Group C:CMS-D002 Capsules 50 mg, QD;Group D:Placebo, QD |
| Registration date | Nov 12, 2025 |
| Target size | Group A:30;Group B:30;Group C:30;Group D:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: